Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study - PubMed

Novartis Pharma.
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov